Intrepidstudies.com

Visit intrepidstudies.com
  • 6 days ago

    Last scanned

  • 5 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Intrepidstudies.com

Visit intrepidstudies.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

AstraZeneca - Research-Based BioPharmaceutical Company

AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon Technologies Inc., which reserves the following IP addresses for intrepidstudies.com: 165.160.13.20, 165.160.15.20. Moreover, DNS used with this website include dns1.comlaude-dns.com, dns2.comlaude-dns.net, dns3.comlaude-dns.co.uk, dns4.comlaude-dns.eu. Subnet identifier ranges from 18.32.0.0 to 18.255.255.255. Classless Inter-Domain Routing (CIDR) is 18.128.0.0/9, 18.64.0.0/10, 18.32.0.0/11. ARIN net type is Direct Allocation.

  • 6 days ago

    Last scanned

  • 5 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Network

ADDRESSING DETAILS

Whois

Domain & Keywords

The registrar of intrepidstudies.com is Nom-iq Ltd. dba COM LAUDE and the name expires on 2025-09-07. According to open source data, you can reach the owner at intrepidstudies.com-Registrant@anonymised.email but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.

  • ibd
  • ulcerative colitis
  • clinical trials
  • Gastroenterology
  • Crohn’s disease
  • brazikumab
  • Allergan Gastroenterology
  • Brazikumab IBD
  • Brazikumab clinical trials

Websites similar to intrepidstudies.com